Senate Confirms Dr. Robert Califf as New FDA Commissioner

March 6, 2016

On Feb. 24, the Senate confirmed Dr. Robert Califf, as the new U.S. Food and Drug Administration (FDA) Commissioner by a vote of 89-4. Senators Markey (D-Mass.), Manchin (D-W.VA.), Blumenthal (D-Conn.), and Ayotte (R-N.H.) voted no.

CLSA was pleased to see Dr. Califf confirmed as Commissioner of the FDA. His well-established record as the FDA’s Deputy Commissioner for Medical Products and Tobacco as well as his role serving as a professor and vice chancellor at the Duke University School of Medicine, and as director of the Duke Translational Medicine Institute, demonstrates a commitment to FDA’s public health and safety mission.

CLSA believes Dr. Califf will continue to improve the agency’s drug and device approval processes to ensure that patients receive the safest and most effective treatments as quickly as possible while incorporating patient and consumer feedback into the regulatory process.

CLSA Pres. & CEO Sara Radcliffe applauded Dr. Califf’s nomination, noting, “Dr. Califf has committed to better incorporating patient and consumer feedback into the regulatory process, and expanding technological capabilities to engage more patients and caregivers to better inform product safety and technology development. On behalf of the more than 750 life sciences organizations we represent, California Life Sciences Association strongly supports this confirmation, and we look forward to continuing our collaboration with the FDA and Dr. Califf to meet our shared goals.”

Click here to view CLSA’s full statement applauding Dr. Califf’s confirmation.

Questions? Please contact Jenny Carey, CLSA’s Vice President, Federal Government Relations & Alliance Development ( or 202-743-7559) or Meghan Drenan, CLSA’s Associate Director of Federal Government Relations ( or 202-743-7560).